The adverse event occurred in a 35-year-old participant with no co-morbidities, who was part of Phase 1 trials. The participant was hospitalised with viral pneumonitis, a couple of days after being administered the vaccineCOVID-19 Vaccine | Bharat Biotech#39;s Covaxin reported adverse event during Phase 1 trials, trials not halted
The adverse event occurred in a 35-year-old participant with no co-morbidities, who was part of Phase 1 trials. The participant was hospitalised with viral pneumonitis, a couple of days after being administered the vaccine
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment